Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
Shanbeh Zienolddiny, Vidar SkaugSection for Toxicology and Biological Work Environment, National Institute of Occupational Health, Oslo, NorwayAbstract: Lung cancer is a major public health problem throughout the world. Among the most frequent cancer types (prostate, breast, colorectal, stomach, lun...
Guardado en:
Autores principales: | Zienolddiny S, Skaug V |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e434ef5be43b4ac38b66ab8559f87faa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effectiveness of maintenance treatments for nonsmall cell lung cancer
por: Eadens MJ, et al.
Publicado: (2011) -
Prognostic value of single‐nucleotide polymorphisms for extranodal natural killer/T‐cell lymphoma: the identification of risk factors in the molecular era
por: Sang Eun Yoon, et al.
Publicado: (2021) -
Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study
por: Jie Zhang PhD, et al.
Publicado: (2021) -
Hypofractionated stereotactic body radiation therapy for elderly patients with stage IIB–IV nonsmall cell lung cancer who are ineligible for or refuse other treatment modalities
por: Karam SD, et al.
Publicado: (2014) -
Single nucleotide polymorphisms and unacceptable late toxicity in breast cancer adjuvant radiotherapy: a case report
por: Lazzari G, et al.
Publicado: (2017)